A Phase II, Open-Label, Randomized, Multi-Centre Study of Neoadjuvant Olaparib in Patients with Platinum Sensitive Recurrent High Grade Serous Ovarian/Primary Peritoneal or Fallopian tube Cancer
Trial Number
NCT02489006 (ClinicalTrials.gov ID)Contact Person
Status
Closed to Recruitment
Disease Site
Ovarian